Encorafenib, binimetinib, and cetuximab combination therapy for patients with BRAF V600E mutant colorectal cancer

被引：0
|
作者：
Moro, Kazuki [1 ,2 ]
Saiki, Takuro [1 ]
Sasaki, Kenta [1 ]
Matsumoto, Akio [2 ]
Zhou, Qiliang [1 ]
Nakano, Mae [2 ]
Nakano, Masato [2 ]
Matsumoto, Yoshifumi [1 ]
Shimada, Yoshifumi [2 ]
Moriyama, Masato [1 ]
Wakai, Toshifumi [2 ]
Saijo, Yasuo [1 ]
机构：
[1] Niigata Univ, Dept Med Oncol, Niigata, Japan
[2] Niigata Univ, Div Digest & Gen Surg, Niigata, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.347
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P74-1
引用
收藏
页码：S541 / S541
页数：1
相关论文
共 50 条
  • [41] Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib plus /- binimetinib or alpelisib
    Huijberts, Sanne C. F. A.
    Boelens, Mirjam C.
    Bernards, Rene
    Opdam, Frans L.
    [J]. BRITISH JOURNAL OF CANCER, 2021, 124 (01) : 176 - 182
  • [42] BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression
    Barras, David
    Missiaglia, Edoardo
    Wirapati, Pratyaksha
    Sieber, Oliver M.
    Jorissen, Robert N.
    Love, Chris
    Molloy, Peter L.
    Jones, Ian T.
    McLaughlin, Stephen
    Gibbs, Peter
    Guinney, Justin
    Simon, Iris M.
    Roth, Arnaud D.
    Bosman, Fred T.
    Tejpar, Sabine
    Delorenzi, Mauro
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (01) : 104 - 115
  • [43] BAYONET trial: A multicenter phase II trial of staged combination with encorafenib plus binimetinib plus cetuximab following encorafenib plus cetuximab in patients with BRAFV600E-mutant metastatic colorectal cancer.
    Matsubara, Yuki
    Bando, Hideaki
    Kotani, Daisuke
    Kagawa, Yoshinori
    Harada, Kazuaki
    Osumi, Hiroki
    Izawa, Naoki
    Kawakami, Takeshi
    Boku, Shogen
    Matsumoto, Toshihiko
    Wakabayashi, Masashi
    Yoshino, Takayuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS271 - TPS271
  • [44] Cost-effectiveness of encorafenib plus cetuximab in BRAF V600E-mutated colorectal cancer
    Giuliani, Jacopo
    Mantoan, Beatrice
    Bonetti, Andrea
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (01) : 199 - 202
  • [45] A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
    Baik, Christina
    Cheng, Michael L.
    Dietrich, Martin
    Gray, Jhanelle E.
    Karim, Nagla A.
    [J]. ADVANCES IN THERAPY, 2024, 41 (07) : 2586 - 2605
  • [46] A multicenter phase II clinical study evaluating the efficacy and safety of perioperative encorafenib, binimetinib plus cetuximab combination treatment in patients with surgically resectable BRAF V600E-mutant colorectal oligometastases (NEXUS)
    Kobayashi, S.
    Bando, H.
    Taketomi, A.
    Takamoto, T.
    Shinozaki, E.
    Shiozawa, M.
    Hara, H.
    Yamazaki, K.
    Komori, K.
    Matsuhashi, N.
    Kato, T.
    Kagawa, Y.
    Yokota, M.
    Oki, E.
    Takahashi, S.
    Yoshino, T.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S736 - S737
  • [47] Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer (The BEACON CRC Study)
    Velez, L.
    Trevino, T.
    Kopetz, S.
    Grothey, A.
    Yaeger, R.
    Gollerkeri, A.
    Maharry, K.
    Tabernero, J.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S224 - S225
  • [48] BRAF V600E: PROGNOSTIC MARKER IN COLORECTAL CANCER
    Plestina, S.
    Rako, I.
    Jakic-Razumovic, J.
    Katalinic, D.
    Sertic, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 86 - 86
  • [49] Safety and efficacy of encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer: A systematic review and single-arm meta-analysis
    Celso, D. S. G.
    Defante, M. L. R.
    Alzogaray, V.
    Torres, L. A.
    Lopes, A. C. Melo
    Bearse, M.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S29 - S29
  • [50] Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience
    Boccaccino, A.
    Borelli, B.
    Intini, R.
    Antista, M.
    Bensi, M.
    Rossini, D.
    Passardi, A.
    Tamberi, S.
    Giampieri, R.
    Antonuzzo, L.
    Noto, L.
    Roviello, G.
    Zichi, C.
    Salati, M.
    Puccini, A.
    Noto, C.
    Parisi, A.
    Rihawi, K.
    Persano, M.
    Crespi, V
    Libertini, M.
    Giordano, M.
    Moretto, R.
    Lonardi, S.
    Cremolini, C.
    [J]. ESMO OPEN, 2022, 7 (03)
12345